Basic Principles of Mechanical Ventilation
Initial Mode Selection
Start with volume-cycled Assist-Control (AC) ventilation when initiating mechanical ventilation, as this provides complete ventilatory support immediately after intubation and prevents central apneas. 1, 2, 3
- AC mode guarantees a preset number of mandatory breaths per minute while allowing patient-triggered breaths, with all breaths delivering identical preset tidal volume. 1, 3
- Synchronized Intermittent Mandatory Ventilation (SIMV) can achieve similar respiratory support and may be used as an alternative. 4, 3
- Pressure Support Ventilation (PSV) should not be used as the initial mode but may be considered during weaning or for prolonged ventilation in stable patients. 3
Critical Initial Ventilator Settings
Set tidal volume at 6 mL/kg predicted body weight (PBW)—not actual body weight—to reduce mortality in ARDS and sepsis-induced respiratory failure. 4, 2, 3, 5
Calculating Predicted Body Weight:
Pressure Limits:
- Maintain plateau pressure ≤30 cmH₂O to prevent alveolar overdistension and ventilator-induced lung injury (VILI). 4, 2, 3, 5
- Monitor driving pressure (ΔP = Plateau pressure - PEEP), keeping it <15 cmH₂O, as this predicts outcomes better than any other ventilatory parameter. 4
Oxygenation Targets:
- Target PaO₂ 70-90 mmHg or SaO₂ 92-97%—avoid both hypoxemia and hyperoxia. 4
- Hyperoxia increases lung inflammation, adversely affects microcirculation, and is associated with increased mortality. 4
PEEP Strategy
Apply PEEP appropriately based on gas exchange, hemodynamic status, lung recruitability, end-expiratory transpulmonary pressure, and driving pressure. 4
- Perform recruitment maneuvers before PEEP selection. 4
- Use higher PEEP for moderate-severe ARDS (PaO₂/FiO₂ < 150 mmHg). 2
- PEEP ameliorates changes in closing volume and lung derecruitment, providing dramatic improvements in PaO₂. 4
- Consider esophageal pressure measurement to estimate transpulmonary pressure for individualized PEEP titration. 4
Indications for Invasive Mechanical Ventilation
Proceed to intubation and invasive ventilation when any of the following are present:
- Life-threatening hypoxemia: PaO₂/FiO₂ ≤150 mmHg, particularly if <100 mmHg despite optimized oxygen therapy. 2
- Severe tachypnea: respiratory rate >35 breaths/min despite optimal medical therapy. 4, 2
- Refractory hypoxemia: PaO₂ <60 mmHg despite high-flow oxygen. 4
- Respiratory distress with increased work of breathing and signs of respiratory muscle fatigue despite oxygen and noninvasive support. 2
- Impaired mental status or inability to protect the airway. 4, 2
- Severe acidosis: pH <7.25 with hypercapnia. 2
- Cardiovascular instability complicating respiratory failure (hypotension, arrhythmias, myocardial infarction). 2
Noninvasive Support Considerations
Noninvasive support with close monitoring is reasonable in less severely ill patients, but requires vigilant assessment for failure. 4
- High-flow nasal cannula (HFNC) reduces intubation rates and improves survival in patients with PaO₂/FiO₂ ≤200 mmHg compared to standard oxygen or face-mask NIV. 4
- If noninvasive support fails to improve within 1-2 hours, proceed immediately to invasive ventilation—delayed intubation increases mortality. 4, 2
- Monitored tidal volumes persistently >9.5 mL/kg PBW during NIV suggest the need for intubation. 4
- Rapid shallow breathing index (RSBI) >105 breaths/min/L is associated with need for intubation. 4
Airway Management
Use orotracheal intubation as the preferred route due to increased rates of nosocomial sinusitis with nasotracheal tubes, which contributes to ventilator-associated pneumonia (VAP) and mortality. 4
Adjunctive Therapies for Severe ARDS (PaO₂/FiO₂ <150 mmHg)
When PaO₂/FiO₂ <150 mmHg despite optimized ventilation, implement the following:
- Prone positioning for >12 hours per day—this improves oxygenation in approximately 65% of patients. 4, 2
- Consider neuromuscular blocking agents within the first 48 hours for severe refractory hypoxemia, especially with ventilator-patient dyssynchrony. 4, 2
- Deep sedation and analgesia within the first 48 hours of mechanical ventilation. 2
Rescue Therapies for Refractory ARDS
Consider ECMO when:
- PaO₂/FiO₂ <100 mmHg despite optimized PEEP and neuromuscular blockade 2
- pH <7.15 with excessive compensatory respiratory acidosis 2
- Plateau pressure >30 cmH₂O despite lung-protective ventilation 2
- Mechanical power ≥27 J/min 2
Fluid Management
Advocate judicious fluid resuscitation and/or fluid restriction when possible in ARDS, as improvements in physiology and outcome occur when patients lose weight or microvascular pressures fall. 4
- Fluid restriction strategies do not increase complications such as renal failure or hemodynamic compromise. 4
- In hypo-oncotic patients with established lung injury, albumin combined with furosemide may improve physiology and reduce duration of mechanical ventilation. 4
Critical Pitfalls to Avoid
Never use actual body weight for tidal volume calculations—always use predicted body weight. 2, 3
Never hyperventilate patients—target normocapnia (PaCO₂ 40-45 mmHg) to prevent cerebral vasoconstriction, hemodynamic instability, and increased mortality. 2, 3
Do not delay intubation when noninvasive support fails—delayed intubation is associated with increased mortality. 4
Avoid high-frequency oscillatory ventilation (HFOV) routinely in ARDS—it does not improve outcomes and may be harmful. 2, 3
Monitor for patient-ventilator dyssynchrony closely, as even assisted ventilation can induce VILI through generation of high tidal volumes and transpulmonary pressures. 3
Monitoring Requirements
Continuously monitor the following parameters:
- Plateau pressure, driving pressure, and oxygenation index 2
- Patient-ventilator synchrony 2
- Serial arterial blood gases to guide ventilator adjustments 2
- Pulse oximetry and capnography for adequate oxygenation and ventilation 2
Weaning Considerations
Consider weaning when PaO₂/FiO₂ >200 mmHg and PEEP <10 cmH₂O. 4
- Reduce sedation and transition to partial ventilator support to promote respiratory muscle activity when gas exchange, respiratory mechanics, and hemodynamic status have improved. 4